[HTML] nih.gov

[HTML][HTML] A case report of leptomeningeal carcinomatosis secondary to recurrent merkel cell Carcinoma after Avelumab

P Mendoza, KL Chuang - The Permanente Journal, 2021 - ncbi.nlm.nih.gov
A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell
Carcinoma after Avelumab - PMC Back to Top Skip to main content NIH NLM Logo Access keys …
被引用次数：2 相关文章

A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell Carcinoma after Avelumab.

P Mendoza, KL Chuang - The Permanente Journal, 2021 - europepmc.org
A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell
Carcinoma after Avelumab. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell Carcinoma after Avelumab

P Mendoza, KL Chuang - The Permanente journal, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine cancer
with a high mortality rate of 33% to 46%. Merkel cell is a type of epidermis cell receptor …

A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell Carcinoma after Avelumab.

P Mendoza, K Lin Chuang - Permanente Journal, 2021 - search.ebscohost.com
Introduction: Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine cancer
with a high mortality rate of 33% to 46%. Merkel cell is a type of epidermis cell receptor …

A Case Report of Leptomeningeal Carcinomatosis Secondary to Recurrent Merkel Cell Carcinoma after Avelumab

P Mendoza, KL Chuang - The Permanente Journal, 2021 - thepermanentejournal.org
Introduction: Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine cancer
with a high mortality rate of 33% to 46%. Merkel cell is a type of epidermis cell receptor …